Appl Clin Inform 2017; 08(02): 348-368
DOI: 10.4338/ACI-2016-10-R-0175
Review
Schattauer GmbH

Technology-Mediated Interventions and Quality of Life for Persons Living with HIV/AIDS

A Systematic Review
Hwayoung Cho
1  Columbia University School of Nursing, New York, United States
,
Sarah Iribarren
2  Department of Biobehavioral Nursing and Health Informatics, University of Washington, Seattle, United States
,
Rebecca Schnall
1  Columbia University School of Nursing, New York, United States
› Author Affiliations
Funding This work was supported by the Agency for Healthcare Research and Quality under award number R21HS023963 (PI: Schnall) and the National Institute of Nursing Research of the National Institute of Health under award number R01NR015737 (PI: Schnall). At the time of this study, Dr. Sarah Iribarren was funded by a Comparative and Cost-Effectiveness Research Training for Nurse Scientists Award (T32-NR014205; PI: Stone) by the National Institute of Nursing Research of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality or the National Institute of Health.
Further Information

Publication History

received: 16 October 2016

accepted: 27 January 2017

Publication Date:
21 December 2017 (online)

Summary

Background: As HIV/AIDS is considered a chronic disease; quality of life (QoL) has become an important focus for researchers and healthcare providers. Technology-mediated interventions have demonstrated improved clinical effectiveness in outcomes, such as viral suppression, for persons living with HIV/AIDS (PLWH). However, the evidence to support the impact of these interventions on QoL is lacking.

Objectives: The aim of this paper was to assess the impact of technology-mediated interventions on QoL and to identify the instruments used to measure the QoL of PLWH.

Methods: For this review we followed the PRISMA guidelines. A literature search was conducted in PubMed, CINAHL, Cochrane, and EMBASE databases in April 2016. Inclusion criteria limited articles to those with technology-mediated interventions as compared to usual care; articles with the population defined as HIV-infected patients; and articles with QoL measured as a health outcome in randomized controlled trials. The Cochrane Collaboration Risk of Bias Tool was used to assess study quality.

Results: Of the 1,554 peer-reviewed articles returned in the searches, 10 met the inclusion criteria. This systematic review identified four types of technology-mediated interventions and two types of QoL instruments used to examine the impact of technology-mediated interventions on PLWH. Four studies of technology-mediated interventions resulted in improvement in QoL. Four studies considered QoL as a secondary outcome and resulted in a negative or neutral impact on QoL. Overall, four studies had a low risk of bias, one study had a moderate risk of bias, and the other five studies had a high risk of bias.

Conclusions: The evidence to support the improvement of QoL using technology-mediated interventions is insufficient. This lack of research highlights the need for increased study of QoL as an outcome measure and the need for consistent measures to better understand the role of technology-mediated interventions in improving QoL for PLWH.

Citation: Hwayoung Cho, Sarah Iribarren, Rebecca Schnall. Technology-Mediated Interventions and Quality of Life for Persons Living with HIV/AIDS: A Systematic Review. Appl Clin Inform 2017; 8: 348–368 https://doi.org/10.4338/ACI-2016-10-R-0175

Clinical Relevance Statement

Although technology-mediated interventions have been considered an effective tool in HIV/AIDS care, and quality of life has been recognized as an important outcome for persons living with HIV, the impact of technology-mediated interventions on quality of life still remains unclear. This review has implications for future research evaluating the effectiveness of technology-mediated interventions on quality of life as a primary outcome using a validated instrument in persons living with HIV.


Human Subjects Protections

Human and/or animal subjects were not included in this review.